{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:10:34Z","timestamp":1790989834089,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001390.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T00:00:00Z","timestamp":1485216000000}}],"reference-count":163,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001390.pub4","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T22:30:06Z","timestamp":1485210606000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2019","author":[{"given":"Julia AE","family":"Walters","sequence":"first","affiliation":[{"name":"La Trobe University; 55 Commercial Rd Alfred Health Clinical School Melbourne Victoria Australia 3004"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne Ngie Qing","family":"Tang","sequence":"additional","affiliation":[{"name":"University of Tasmania; School of Medicine; Hobart Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillippa","family":"Poole","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Medicine; Private Bag 92019 Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wood-Baker","sequence":"additional","affiliation":[{"name":"University of Tasmania; School of Medicine; Hobart Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,1,24]]},"reference":[{"issue":"4 Suppl","key":"10.1002\/14651858.CD001390.pub4-BIB0001|cit1","first-page":"837S","article-title":"Clinical efficacy of pneumococcal vaccine in COPD patients. Preliminary results","volume":"126","author":"Alfageme","year":"2004","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/thx.2005.043323","article-title":"Clinical efficacy of anti-pneumococcal vaccination in patients with COPD","volume":"61","author":"Alfageme","year":"2006","journal-title":"Thorax"},{"issue":"Suppl","key":"10.1002\/14651858.CD001390.pub4-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1378\/chest.85.6_Supplement.82S-a","article-title":"Effects of 14-valent pneumococcal capsular polysaccharide vaccine in patients with COPD","volume":"85","author":"Davis","year":"1984","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1378\/chest.92.2.204","article-title":"Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study","volume":"92","author":"Davis","year":"1987","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1093\/cid\/cis513","article-title":"Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease","volume":"55","author":"Dransfield","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1164\/rccm.200903-0488OC","article-title":"Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease","volume":"180","author":"Dransfield","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0007|cit7","unstructured":"NCT00457977 Comparing two pneumococcal vaccines in adults with chronic obstructive pulmonary disease (PNEUMO) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00457977"},{"issue":"33","key":"10.1002\/14651858.CD001390.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1016\/j.vaccine.2008.05.037","article-title":"Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease","volume":"26","author":"Furumoto","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0009|cit9","first-page":"28","article-title":"[The clinical aspects of efficiency of the prevention of pneumococcal infection with vaccines in chronic obstructive pulmonary disease patients living in the West Siberian Region]. [Russian]","volume":"86","author":"Kostinov","year":"2014","journal-title":"Terapevticheskii Arkhiv"},{"issue":"4","key":"10.1002\/14651858.CD001390.pub4-BIB0010|cit10","first-page":"361","article-title":"Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease","volume":"136","author":"Leech","year":"1987","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0011|cit11","unstructured":"NCT01381367 PPSV23 pneumococcal vaccine in chronic obstructive pulmonary disease (COPD) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01381367"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.vaccine.2005.09.020","article-title":"Response to pneumococcal vaccine in chronic obstructive lung disease - the effect of ongoing, systemic steroid treatment","volume":"24","author":"Steentoft","year":"2006","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0013|cit13","unstructured":"Teramoto S Yamamoto H Yamaguchi Y Hanaoka Y Ishil M Ouchi Y Clinical efficacy of anti-pneumococcal vaccination in elderly patients with COPD [Abstract] American Thoracic Society International Conference; 2007 May 18-23; San Francisco 2007 A137"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0014|cit14","first-page":"41","article-title":"[Effect of pneumo 23 vaccine administration in patients with chronic obstructive pulmonary disease of intermediate severity]. [Russian]","volume":"4","author":"Trofimov","year":"2010","journal-title":"Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii"},{"issue":"Suppl 50","key":"10.1002\/14651858.CD001390.pub4-BIB0015|cit15","first-page":"178s [P1091]","article-title":"Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD) [Abstract]","volume":"28","author":"Ya Tseimakh","year":"2006","journal-title":"European Respiratory Journal"},{"issue":"Meeting Abstrac","key":"10.1002\/14651858.CD001390.pub4-BIB0016|cit16","first-page":"A2182","article-title":"Impact of pneumococcal polysaccharide vaccine on acute exacerbation and quality of life in COPD patients (Abstract)","volume":"187","author":"Yilmaz","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001390.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/00325481.1996.11946098","article-title":"Acute exacerbations of chronic bronchitis: focusing management for optimum results","volume":"99","author":"Aboussouan","year":"1996","journal-title":"Postgraduate Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0018|cit18","first-page":"184","article-title":"Prevention of pneumococcal pneumonia by vaccination","volume":"89","author":"Austrian","year":"1976","journal-title":"Transactions of the Association of American Physicians"},{"issue":"Suppl","key":"10.1002\/14651858.CD001390.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/clinids\/3.Supplement_1.S1","article-title":"Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention","volume":"3","author":"Austrian","year":"1981","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJM198403083101010","article-title":"A reassessment of pneumococcal vaccine","volume":"310","author":"Austrian","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0021|cit21","first-page":"128","article-title":"Anti-pneumococci vaccine: justifications and results","volume":"53","author":"Bacle","year":"1997","journal-title":"Revue de Pneumologie Clinique"},{"issue":"Suppl","key":"10.1002\/14651858.CD001390.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1093\/clinids\/3.Supplement_1.S61","article-title":"Pneumococcal vaccine in the institutionalized elderly: review of past and recent studies","volume":"3","author":"Bentley","year":"1981","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-104-1-1","article-title":"Pneumococcal vaccine efficacy in selected populations in the United States","volume":"104","author":"Bolan","year":"1986","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD001390.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1093\/clinids\/3.Supplement_1.S82","article-title":"Efficacy of pneumococcal polysaccharide vaccines","volume":"3","author":"Broome","year":"1981","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0025|cit25","unstructured":"Butler JC Breiman RF Campbell JF Efficacy of the pneumococcal vaccine: Is once enough? 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1992 11-14 Oct; Anaheim 1992"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jinf.2012.04.014","article-title":"Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan-a representative population-based comparative study","volume":"65","author":"Chang","year":"2012","journal-title":"Journal of Infection"},{"issue":"Suppl 6A","key":"10.1002\/14651858.CD001390.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"87S","DOI":"10.1016\/0002-9343(91)90317-Q","article-title":"Treatment of acute exacerbations of chronic bronchitis: state of the art","volume":"91","author":"Chodosh","year":"1991","journal-title":"American Journal of Medicine"},{"issue":"9261","key":"10.1002\/14651858.CD001390.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(00)04237-9","article-title":"Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years of older: a prospective study","volume":"357","author":"Christenson","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0030|cit30","unstructured":"Dilokthornsakul P Lee TA The association between pneumococcal vaccine and thrombocytopenia in elderly patients with chronic obstructive pulmonary disease: a case-crossover study 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2014 Oct 24-27; Taipei 2014"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1445-5994.1979.tb04152.x","article-title":"Pneumococcal disease and its prevention with polyvalent pneumococcal polysaccharide vaccines - a review","volume":"9","author":"Douglas","year":"1979","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/infdis\/149.6.861","article-title":"Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children","volume":"149","author":"Douglas","year":"1984","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2307\/4582686","article-title":"Studies on immunizing substances in pneumococci","volume":"53","author":"Ekwurzel","year":"1938","journal-title":"Public Health Reports"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00045413-199901000-00001","article-title":"Chronic obstructive pulmonary disease and infection: from stable patients to pneumonia","volume":"6","author":"Ewig","year":"1999","journal-title":"Clinical Pulmonary Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1001\/archinte.1995.00430210086013","article-title":"Preventing pneumococcal bacteremia in patients at risk","volume":"155","author":"Farr","year":"1995","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF01645568","article-title":"Immunization of elderly people with polyvalent pneumococcal vaccine","volume":"617","author":"Fedson","year":"1989","journal-title":"Infection"},{"issue":"22","key":"10.1002\/14651858.CD001390.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1001\/archinte.1994.00420220021003","article-title":"Pneumococcal vaccine after 15 years of use. Another view","volume":"154","author":"Fedson","year":"1994","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0264-410X(99)00113-9","article-title":"The clinical effectiveness of pneumococcal vaccination: a brief review","volume":"17","author":"Fedson","year":"1999","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2307\/4582686","article-title":"Studies on immunizing substances in pneumococci","volume":"53","author":"Felton","year":"1938","journal-title":"Public Health Reports"},{"issue":"17","key":"10.1002\/14651858.CD001390.pub4-BIB0040|cit40","first-page":"1017","article-title":"Management of chronic obstructive pulmonary disease","volume":"328","author":"Ferguson","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archinte.1990.00390190039001","article-title":"Pneumoccal vaccines and public health policy","volume":"150","author":"Filice","year":"1990","journal-title":"Archives of Internal Medicine"},{"issue":"23","key":"10.1002\/14651858.CD001390.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1001\/archinte.1994.00420230051007","article-title":"Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials","volume":"154","author":"Fine","year":"1994","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-9343(87)90751-0","article-title":"Inefficacy of pneumococcal vaccine in a high-risk population","volume":"83","author":"Forrester","year":"1987","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0044|cit44","first-page":"39","article-title":"Infectious exacerbations of chronic pulmonary diseases. Therapeutic effectiveness of immunomodulants","volume":"43","author":"Foschino","year":"1995","journal-title":"Minerva Pneumologica"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1001\/jama.1990.03450220076026","article-title":"Pneumococcal vaccine: efficacy and associated cost savings","volume":"264","author":"Gable","year":"1990","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0046|cit46","first-page":"437","article-title":"Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions","volume":"33","author":"Gaillat","year":"1985","journal-title":"Revue d'Epidemiologie et de Sante Publique"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1586\/ers.09.53","article-title":"Should patients with chronic obstructive pulmonary disease be vaccinated against pneumococcal diseases?","volume":"3","author":"Gaillat","year":"2009","journal-title":"Expert Review of Respiratory Medicine"},{"issue":"17","key":"10.1002\/14651858.CD001390.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1056\/NEJM199304293281708","article-title":"Immunization of adults","volume":"328","author":"Gardner","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1002\/14651858.CD001390.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.vaccine.2014.02.002","article-title":"Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults 60-64 years of age","volume":"32","author":"Greenberg","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/15412555.2010.527736","article-title":"The COPD pipeline VII","volume":"7","author":"Gross","year":"2010","journal-title":"COPD"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jech.52.2.120","article-title":"Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands","volume":"52","author":"Hak","year":"1998","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0052|cit52","first-page":"109","article-title":"Clinical efficacy of autovaccine in the treatment of infectious nonatopic asthma and COPD - double blind placebo controlled trial","volume":"6","author":"Halasa","year":"2001","journal-title":"Alergia Astma Immunologia"},{"issue":"4","key":"10.1002\/14651858.CD001390.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1513\/pats.201102-016RM","article-title":"Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease","volume":"8","author":"Han","year":"2011","journal-title":"Proceedings of the American Thoracic Society"},{"issue":"Suppl","key":"10.1002\/14651858.CD001390.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/clinids\/3.Supplement_1.S31","article-title":"Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines","volume":"3","author":"Hilleman","year":"1981","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/jama.1981.03320130034020","article-title":"Pneumococcal vaccine in the United States: a critical analysis","volume":"246","author":"Hirschmann","year":"1981","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archinte.1994.00420040023005","article-title":"The pneumococcal vaccine after 15 years of use","volume":"154","author":"Hirschmann","year":"1994","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl II","key":"10.1002\/14651858.CD001390.pub4-BIB0057|cit57","first-page":"ii24","article-title":"Pneumococcal and influenza vaccination: current situation and future prospects","volume":"57","author":"Horwood","year":"2002","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0058|cit58","unstructured":"Hughes JM Dransfield MT Predictors of colonisation of pneumococcus in patients with COPD (Abstract) http:\/\/www.atsjournals.org\/doi\/pdf\/10.1164\/ajrccm-conference.2011.183.1_MeetingAbstracts.A4565"},{"issue":"9","key":"10.1002\/14651858.CD001390.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/656587","article-title":"Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study","volume":"51","author":"Hung","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"18","key":"10.1002\/14651858.CD001390.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"Jackson","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jinf.2005.11.020","article-title":"Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain","volume":"54","author":"Jimenez-Garcia","year":"2007","journal-title":"Journal of Infection"},{"issue":"4","key":"10.1002\/14651858.CD001390.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1183\/09031936.02.00289702","article-title":"Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine","volume":"20","author":"Jonsson","year":"2002","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jama.1974.03240030022019","article-title":"Prospectus: the prevention of bacteremic pneumococcal pneumonia. A conservative appraisal of vaccine intervention","volume":"230","author":"Kaiser","year":"1974","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archinte.1941.00200020066004","article-title":"Studies on old age pneumonia II. Prophylactic effect of pneumococcus polysaccharide against pneumonia","volume":"67","author":"Kaufman","year":"1941","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archinte.1947.00220110058004","article-title":"Pneumonia in old age: active immunization against pneumonia with pneumococcus polysaccharide: results of a six-year study","volume":"79","author":"Kaufman","year":"1947","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0277-5379(86)90367-6","article-title":"Placebo controlled pneumococcal immunisation in patients with bronchogenic carcinoma","volume":"22","author":"Klastersky","year":"1986","journal-title":"European Journal of Cancer and Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD001390.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1001\/archinte.1983.00350100040012","article-title":"Pneumococcal vaccine in the hospital. Improved use and implications for high-risk patients","volume":"143","author":"Klein","year":"1983","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(97)00149-6","article-title":"Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial","volume":"103","author":"Koivula","year":"1997","journal-title":"American Journal of Medine"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02123671","article-title":"Pneumococcal antibodies (IgG, IgM) in patients with chronic obstructive lung disease 3 years after pneumococcal vaccination","volume":"174","author":"Kraus","year":"1985","journal-title":"Medical Microbiology and Immunology"},{"issue":"4","key":"10.1002\/14651858.CD001390.pub4-BIB0070|cit70","first-page":"293","article-title":"Pneumococcal vaccine","volume":"4","author":"LaForce","year":"1989","journal-title":"Seminars in Respiratory Infections"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0929-6646(09)60240-0","article-title":"Antibody responses to pneumococcal polysaccharide vaccine in Taiwanese patients with chronic obstructive pulmonary disease","volume":"106","author":"Lai","year":"2007","journal-title":"Journal of the Formosan Medical Association"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1378\/chest.84.4.433","article-title":"Pneumococcal vaccine in elderly patients with COPD","volume":"84","author":"Landesman","year":"1983","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD001390.pub4-BIB0073|cit73","first-page":"163","article-title":"Use of antibiotics, antioxidants, mucolytics and vaccines in the therapy of chronic obstructive pulmonary disease","volume":"3","author":"Larsson","year":"1998","journal-title":"European Respiratory Monograph"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11606-007-0118-3","article-title":"Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma","volume":"22","author":"Lee","year":"2007","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001390.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0399-077X(01)00183-4","article-title":"Anti-pneumococci vaccination: role and indications in the prevention of community acquired infections of the lower respiratory tract","volume":"31","author":"Leophonte","year":"2001","journal-title":"Medecine et Maladies Infectieuses"},{"issue":"11","key":"10.1002\/14651858.CD001390.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4161\/hv.6.11.12852","article-title":"Concomitant administration of zoster and pneumococcal vaccines in adults >60 years old","volume":"6","author":"MacIntyre","year":"2010","journal-title":"Human Vaccines"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.82.6.445","article-title":"Prevention of pneumococcal pneumonia by immunisation with specific capsular polysaccharide","volume":"82","author":"MacLeod","year":"1945","journal-title":"Journal of Experimental Medicine"},{"issue":"9126","key":"10.1002\/14651858.CD001390.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(97)11081-9","article-title":"Chronic obstructive pulmonary disease","volume":"352","author":"Madison","year":"1998","journal-title":"Lancet"},{"issue":"31-32","key":"10.1002\/14651858.CD001390.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1016\/j.vaccine.2006.05.002","article-title":"Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease","volume":"24","author":"Meyer","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001390.pub4-BIB0080|cit80","first-page":"31","article-title":"Vaccination and antioxidant therapy","volume":"39","author":"Monso","year":"2003","journal-title":"Archivos de Bronconeumologia"},{"issue":"20","key":"10.1002\/14651858.CD001390.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/archinte.159.20.2437","article-title":"The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease","volume":"159","author":"Nichol","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"16","key":"10.1002\/14651858.CD001390.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.vaccine.2008.02.021","article-title":"Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study","volume":"26","author":"Ochoa-Gondar","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1471-2458-8-222","article-title":"The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study","volume":"8","author":"Ochoa-Gondar","year":"2008","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1183\/09031936.94.07030446","article-title":"Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis","volume":"7","author":"Orcel","year":"1994","journal-title":"European Respiratory Journal"},{"issue":"9100","key":"10.1002\/14651858.CD001390.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(97)07358-3","article-title":"Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group","volume":"351","author":"Ortqvist","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jama.1981.03310300027014","article-title":"A cost-benefit analysis of immunisation of pneumococcal pneumonia","volume":"245","author":"Patrick","year":"1981","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0087|cit87","doi-asserted-by":"crossref","unstructured":"Preheim L Rytel M Pneumococcal infection after vaccination Lancet 1978 1317","DOI":"10.1016\/S0140-6736(78)92088-3"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pupt.2013.05.006","article-title":"The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes","volume":"27","author":"Ricci","year":"2014","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0140-6736(77)92552-1","article-title":"Immunisation with a polyvalent pneumococcal vaccine: reduction of adult respiratory mortality in a New Guinea Highlands community","volume":"1","author":"Riley","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0090|cit90","first-page":"43","article-title":"Reduction with an immunomodulator of the infection rate in chronic bronchitis","volume":"44","author":"Rochemaure","year":"1988","journal-title":"Revue de Pneumologie Clinique"},{"issue":"7","key":"10.1002\/14651858.CD001390.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00005650-199807000-00004","article-title":"Variation in tertiary prevention and health service utilization among the elderly. The role of urban-rural residence and supplemental insurance","volume":"36","author":"Saag","year":"1998","journal-title":"Medical Care"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1378\/chest.07-0996","article-title":"Pneumococcal vaccination for patients with COPD: current practice and future directions. [Review] [53 refs]","volume":"133","author":"Schenkein","year":"2008","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0093|cit93","first-page":"A1507","article-title":"Predictors of COPD exacerbation in hospital patients, population based cases and controls","volume":"A41","author":"Schnelle","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7326\/0003-4819-96-2-208","article-title":"Pneumococcal vaccine: clinical efficacy and effectiveness","volume":"96","author":"Schwartz","year":"1982","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0095|cit95","first-page":"1","article-title":"Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review","volume":"12","author":"Sehatzadeh","year":"2012","journal-title":"Ontario Health Technology Assessment Series"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-101-3-325","article-title":"A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections","volume":"101","author":"Shapiro","year":"1984","journal-title":"Annals of Internal Medicine"},{"issue":"20","key":"10.1002\/14651858.CD001390.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM198705143162010","article-title":"Pneumococcal vaccine failure","volume":"316","author":"Shapiro","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"323","author":"Shapiro","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0099|cit99","first-page":"21","article-title":"Evidence-based problem solving. What is the efficacy of pneumococcal vaccination in people with asthma?","volume":"7","author":"Sheikh","year":"1999","journal-title":"Asthma in General Practice"},{"issue":"21","key":"10.1002\/14651858.CD001390.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198611203152104","article-title":"Efficacy of pneumococcal vaccine in high risk-patients. Results of a Veterans Administration cooperative study","volume":"315","author":"Simberkoff","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001390.pub4-BIB0101|cit101","first-page":"294","article-title":"Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness","volume":"8","author":"Simberkoff","year":"1993","journal-title":"Seminars in Respiratory Infection"},{"issue":"5","key":"10.1002\/14651858.CD001390.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"653","DOI":"10.7326\/0003-4819-108-5-653","article-title":"The clinical effectiveness of pneumococcal vaccine in the elderly","volume":"108","author":"Sims","year":"1988","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7326\/0003-4819-104-1-79","article-title":"Cost effectiveness of vaccination against pneumococcal pneumonia: an update","volume":"104","author":"Sisk","year":"1986","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03280250039019","article-title":"Protective efficacy of pneumococcal polysaccharide vaccines","volume":"238","author":"Smit","year":"1977","journal-title":"JAMA"},{"issue":"13","key":"10.1002\/14651858.CD001390.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2169\/internalmedicine.47.0799","article-title":"Additive inoculation influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients","volume":"47","author":"Sumitani","year":"2008","journal-title":"Internal Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0106|cit106","first-page":"145","article-title":"Pneumococcal bacteraemia: incidence, outcome and predisposing factors","volume":"9","author":"Amptin","year":"1998","journal-title":"European Journal of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001390.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4161\/hv.19466","article-title":"Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study","volume":"8","author":"Vila-Corcoles","year":"2012","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"Suppl 51","key":"10.1002\/14651858.CD001390.pub4-BIB0108|cit108","first-page":"224s [E1368]","article-title":"Effects of pneumococcal vaccine in patients with chronic respiratory disease [Abstract]","volume":"30","author":"Watanuki","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0109|cit109","first-page":"89","article-title":"Alpha-1-protease inhibitor deficiency and pulmonary emphysema as viewed by pulmonary specialists in private practice","volume":"25","author":"Wencker","year":"1999","journal-title":"Atemwegs-und Lungenkrankheiten"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/infdis\/134.6.571","article-title":"Field trial of an inactivated Mycoplasma pneumoniae vaccine","volume":"134","author":"Wenzel","year":"1976","journal-title":"Journal of Infectious Diseases"},{"issue":"23","key":"10.1002\/14651858.CD001390.pub4-BIB0111|cit111","first-page":"177","article-title":"Pneumococcal vaccines: World Health Organization position paper","volume":"74","author":"World Health Organization","year":"1999","journal-title":"Weekly Epidemiological Record"},{"issue":"17","key":"10.1002\/14651858.CD001390.pub4-BIB0112|cit112","first-page":"150","article-title":"Pneumococcal vaccines: World Health Organization position paper","volume":"25","author":"World Health Organization","year":"1999","journal-title":"Canada Communicable Disease Report"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3181\/00379727-156-39894","article-title":"Studies in human subjects of polyvalent pneumococcal vaccines","volume":"156","author":"Wiebel","year":"1977","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM198009043031004","article-title":"Cost effectiveness of vaccination against pneumococcal pneumonia","volume":"303","author":"Willems","year":"1980","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-104-1-106","article-title":"Pneumococcal vaccine and patients with chronic lung disease","volume":"104","author":"Williams","year":"1986","journal-title":"Annals of Internal Medicine"},{"issue":"4714","key":"10.1002\/14651858.CD001390.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(01)56449-1","article-title":"Prophylactic inoculation against pneumococcus infections","volume":"183","author":"Wright","year":"1914","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/IAI.72.2.818-823.2004","article-title":"Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease","volume":"72","author":"Bogaert","year":"2004","journal-title":"Infection and Immunity"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"9589","key":"10.1002\/14651858.CD001390.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study","volume":"370","author":"Buist","year":"2007","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"46s","DOI":"10.1183\/09031936.03.00078002","article-title":"COPD exacerbations: definitions and classifications","volume":"21","author":"Burge","year":"2003","journal-title":"European Respiratory Journal"},{"issue":"8","key":"10.1002\/14651858.CD001390.pub4-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008865.pub3","article-title":"Pneumococcal vaccines for cystic fibrosis","author":"Burgess","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12890-016-0242-0","article-title":"A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults","volume":"16","author":"Chalmers","year":"2016","journal-title":"BMC Pulmonary Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0124|cit124","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006316.pub3","article-title":"Pneumococcal vaccines for children and adults with bronchiectasis","author":"Chang","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0125|cit125","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0126|cit126","unstructured":"COPD Guidelines Steering Committee The COPD-X plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease, March 2016 http:\/\/www.copdx.org.au\/ (accessed 2 July 2016)"},{"issue":"10","key":"10.1002\/14651858.CD001390.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1164\/rccm.200408-1054OC","article-title":"Exacerbations and time spent outdoors in chronic obstructive pulmonary disease","volume":"171","author":"Donaldson","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0129|cit129","unstructured":"European Respiratory Society Immunisation against respiratory diseases http:\/\/www.erswhitebook.org\/chapters\/immunisation-against-respiratory-diseases\/streptococcus-pneumoniae\/"},{"issue":"9400","key":"10.1002\/14651858.CD001390.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community-acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"The Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijantimicag.2008.07.019","article-title":"A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics\/pharmacodynamics of the antibiotic","volume":"33","author":"File","year":"2009","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0132|cit132","unstructured":"GOLD Executive Committee Global strategy for diagnosis, management, and prevention of COPD http:\/\/www.goldcopd.com (accessed 2 July 2016)"},{"issue":"Suppl 33","key":"10.1002\/14651858.CD001390.pub4-BIB0133|cit133","first-page":"209s","article-title":"Prognosis after hospitalization for acute exacerbations of COPD","volume":"8","author":"Groenewegen","year":"2001","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD001390.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ije\/dyl068","article-title":"Benefits of influenza vaccine in US elderly - appreciating issues of confounding bias and precision","volume":"35","author":"Hak","year":"2006","journal-title":"International Journal of Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD001390.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0137|cit137","first-page":"CD010115.pub2","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","volume":"3","author":"Kew","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD001390.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1524-4733.2010.00772.x","article-title":"Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure","volume":"13","author":"Leidy","year":"2010","journal-title":"Value in Health"},{"issue":"4","key":"10.1002\/14651858.CD001390.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1378\/chest.122.4.1264","article-title":"Pneumonic vs nonpneumonic acute exacerbations of COPD","volume":"122","author":"Lieberman","year":"2002","journal-title":"Chest"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001390.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0141|cit141","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000422.pub3","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Moberley","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jinf.2009.03.003","article-title":"Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease","volume":"58","author":"Molinos","year":"2009","journal-title":"Journal of Infection"},{"issue":"9","key":"10.1002\/14651858.CD001390.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4155\/cli.13.73","article-title":"Pneumococcal vaccination in adults: recent evidence from clinical trials and observational studies","volume":"3","author":"Moseley","year":"2013","journal-title":"Clinical Investigation"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0144|cit144","volume-title":"The Australian Immunisation Handbook","author":"NHMRC: Australian Technical Advisory Group on Immunisation","year":"2013"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001390.pub4-BIB0145|cit145","first-page":"181","article-title":"COPD: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care","volume":"59","author":"National Institute of Clinical Excellence","year":"2004","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0146|cit146","unstructured":"National Clinical Guideline Centre Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care London National Clinical Guideline Centre"},{"issue":"10","key":"10.1002\/14651858.CD001390.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/thorax.57.9.759","article-title":"Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations","volume":"57","author":"Patel","year":"2002","journal-title":"Thorax"},{"issue":"8","key":"10.1002\/14651858.CD001390.pub4-BIB0149|cit149","first-page":"337","article-title":"New trends in the prevention and management of community-acquired pneumonia","volume":"70","author":"Postma","year":"2012","journal-title":"Netherlands Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1183\/09031936.06.00131905","article-title":"COPD is associated with increased mortality in patients with community-acquired pneumonia","volume":"28","author":"Restrepo","year":"2006","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0151|cit151","unstructured":"The Nordic Cochrane Centre Review Manager (RevMan) 2014"},{"issue":"6","key":"10.1002\/14651858.CD001390.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1183\/09031936.00183614","article-title":"Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia","volume":"45","author":"Rodrigo","year":"2015","journal-title":"European Respiratory Journal"},{"issue":"90052","key":"10.1002\/14651858.CD001390.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"398S","DOI":"10.1378\/chest.117.5_suppl_2.398S","article-title":"Toward a consensus definition for COPD exacerbations","volume":"117","author":"Rodriguez-Roisin","year":"2000","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001390.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.161.5.9908022","article-title":"Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease","volume":"161","author":"Seemungal","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD001390.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001390.pub4-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002165","article-title":"Pneumococcal vaccine for asthma","author":"Sheikh","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD001390.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Cataluna","year":"2005","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD001390.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1164\/ajrccm.154.5.8912764","article-title":"Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study","volume":"154","author":"Torres","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"12","key":"10.1002\/14651858.CD001390.pub4-BIB0160|cit160","first-page":"1204","article-title":"Exacerbations of chronic obstructive pulmonary disease","volume":"48","author":"Wedzicha","year":"2003","journal-title":"Respiratory Care"},{"issue":"2","key":"10.1002\/14651858.CD001390.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0029-1202941","article-title":"Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network","volume":"30","author":"Welte","year":"2009","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0162|cit162","unstructured":"World Health Organization WHO position paper on pneumococcal vaccines 2012 http:\/\/www.who.int\/immunization\/position_papers\/PP_pneumococcal_April_2012_summary.pdf"},{"key":"10.1002\/14651858.CD001390.pub4-BIB0163|cit163","unstructured":"World Health Organization Global health estimates - years 2000-2011 http:\/\/www.who.int\/healthinfo\/global_burden_disease\/en\/"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001390.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T18:24:24Z","timestamp":1633026264000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001390.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,24]]},"references-count":163,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001390.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,24]]}}}